{"document_type": "article", "snippet": "Two respected medical voices urged caution on the leading candidate for a malaria vaccine, Mosquirix, while two other expert panels recommended going ahead with pilot projects.", "type_of_material": "News", "web_url": "http://www.nytimes.com/2015/10/24/health/malaria-vaccine-rtss-world-health-programme.html", "subsection_name": null, "blog": [], "section_name": "Health", "source": "The New York Times", "pub_date": "2015-10-24T00:00:00Z", "word_count": "610", "slideshow_credits": null, "news_desk": "Foreign", "byline": {"original": "By DONALD G. McNEIL Jr", "person": [{"firstname": "Donald", "middlename": "G.", "organization": "", "role": "reported", "qualifier": "Jr", "rank": 1, "lastname": "McNEIL"}]}, "abstract": "Two expert panels at World Health Organization recommend moving forward with pilot projects to test malaria vaccines known as RTS, S or Mosquirix, despite concerns that have been raised by groups like Doctors Without Borders about vaccine's efficacy.", "keywords": [{"value": "Malaria", "rank": "1", "name": "subject", "is_major": "Y"}, {"value": "Vaccination and Immunization", "rank": "2", "name": "subject", "is_major": "Y"}, {"value": "World Health Organization", "rank": "3", "name": "organizations", "is_major": "Y"}, {"value": "Doctors Without Borders", "rank": "4", "name": "organizations", "is_major": "N"}, {"value": "Africa", "rank": "5", "name": "glocations", "is_major": "N"}, {"value": "GlaxoSmithKline PLC", "rank": "6", "name": "organizations", "is_major": "N"}, {"value": "New England Journal of Medicine", "rank": "7", "name": "organizations", "is_major": "N"}], "print_page": "4", "multimedia": [{"subtype": "wide", "legacy": {"wideheight": "126", "wide": "images/2015/10/24/science/24MALARIA/24MALARIA-thumbWide.jpg", "widewidth": "190"}, "type": "image", "width": 190, "height": 126, "url": "images/2015/10/24/science/24MALARIA/24MALARIA-thumbWide.jpg"}, {"subtype": "xlarge", "legacy": {"xlargeheight": "400", "xlargewidth": "600", "xlarge": "images/2015/10/24/science/24MALARIA/24MALARIA-articleLarge.jpg"}, "type": "image", "width": 600, "height": 400, "url": "images/2015/10/24/science/24MALARIA/24MALARIA-articleLarge.jpg"}, {"subtype": "thumbnail", "legacy": {"thumbnail": "images/2015/10/24/science/24MALARIA/24MALARIA-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "type": "image", "width": 75, "height": 75, "url": "images/2015/10/24/science/24MALARIA/24MALARIA-thumbStandard.jpg"}], "lead_paragraph": "Two respected medical voices urged caution on the leading candidate for a malaria vaccine, Mosquirix, while two other expert panels recommended going ahead with pilot projects.", "headline": {"print_headline": "Experts Give Mixed News on Vaccine for Malaria", "main": "Leading Malaria Vaccine Gets Mixed Reviews"}, "_id": "562aac6938f0d870a430cd94"}